BG106883A - Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl - Google Patents

Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl

Info

Publication number
BG106883A
BG106883A BG106883A BG10688302A BG106883A BG 106883 A BG106883 A BG 106883A BG 106883 A BG106883 A BG 106883A BG 10688302 A BG10688302 A BG 10688302A BG 106883 A BG106883 A BG 106883A
Authority
BG
Bulgaria
Prior art keywords
dimethylaminomethyl
hydroxycyclohexyl
hydroxybenzoate
phenyl
novel esters
Prior art date
Application number
BG106883A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
Juan HUGUET
Original Assignee
Laboratorios Vita,S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Vita,S.A. filed Critical Laboratorios Vita,S.A.
Publication of BG106883A publication Critical patent/BG106883A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG106883A 1999-12-30 2002-06-28 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl BG106883A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
PCT/ES2000/000486 WO2001049650A1 (fr) 1999-12-30 2000-12-26 Nouveaux esters derives de (rr,ss)-2-hydroxybenzoate de 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyle

Publications (1)

Publication Number Publication Date
BG106883A true BG106883A (en) 2003-05-30

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106883A BG106883A (en) 1999-12-30 2002-06-28 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl

Country Status (30)

Country Link
US (1) US6894076B2 (fr)
EP (1) EP1251120B1 (fr)
JP (1) JP2003519208A (fr)
KR (1) KR20020063281A (fr)
CN (1) CN1414946A (fr)
AP (1) AP1234A (fr)
AT (1) ATE284380T1 (fr)
AU (1) AU775918B2 (fr)
BG (1) BG106883A (fr)
BR (1) BR0016882A (fr)
CA (1) CA2395976A1 (fr)
CZ (1) CZ20022189A3 (fr)
DE (1) DE60016631D1 (fr)
EA (1) EA004770B1 (fr)
EE (1) EE200200365A (fr)
ES (1) ES2160534B1 (fr)
HR (1) HRP20020559A2 (fr)
HU (1) HUP0204147A3 (fr)
IL (1) IL150392A0 (fr)
IS (1) IS6440A (fr)
MA (1) MA26862A1 (fr)
MX (1) MXPA02006514A (fr)
NO (1) NO20023098D0 (fr)
NZ (1) NZ520263A (fr)
OA (1) OA12132A (fr)
PL (1) PL356056A1 (fr)
SK (1) SK9252002A3 (fr)
WO (1) WO2001049650A1 (fr)
YU (1) YU50902A (fr)
ZA (1) ZA200205193B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
EP2383255A1 (fr) 2010-04-28 2011-11-02 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
CA2808219C (fr) 2010-09-02 2019-05-14 Gruenenthal Gmbh Forme pharmaceutique inviolable comportant un sel inorganique
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
EP2530072A1 (fr) 2011-06-03 2012-12-05 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
CA2839123A1 (fr) 2011-07-29 2013-02-07 Grunenthal Gmbh Comprime anti-manipulation permettant une liberation immediate de medicament
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (fr) 2013-05-29 2014-12-04 Grünenthal GmbH Forme dosifiée inviolable à profil de libération bimodale
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (fr) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Préparation de composition pharmaceutique en poudre par cryo-broyage
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
HUE048032T2 (hu) 2015-10-15 2020-05-28 Jiangsu Hengrui Medicine Co Oxaspiro-származék, elõállítási eljárása és alkalmazásai gyógyszerekben

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
JP2003519208A (ja) 2003-06-17
IS6440A (is) 2002-06-25
NO20023098L (no) 2002-06-26
EE200200365A (et) 2003-10-15
EA004770B1 (ru) 2004-08-26
US6894076B2 (en) 2005-05-17
YU50902A (sh) 2006-01-16
OA12132A (en) 2006-05-05
EP1251120A1 (fr) 2002-10-23
NZ520263A (en) 2004-07-30
HUP0204147A2 (hu) 2003-04-28
MXPA02006514A (es) 2004-07-30
AU2012601A (en) 2001-07-16
EA200200614A1 (ru) 2002-12-26
KR20020063281A (ko) 2002-08-01
DE60016631D1 (de) 2005-01-13
CZ20022189A3 (cs) 2003-03-12
ES2160534A1 (es) 2001-11-01
SK9252002A3 (en) 2003-04-01
US20030100598A1 (en) 2003-05-29
BR0016882A (pt) 2002-11-05
HUP0204147A3 (en) 2003-10-28
ZA200205193B (en) 2003-06-27
EP1251120B1 (fr) 2004-12-08
AP2002002571A0 (en) 2002-09-30
NO20023098D0 (no) 2002-06-26
ES2160534B1 (es) 2002-04-16
IL150392A0 (en) 2002-12-01
AP1234A (en) 2003-12-28
HRP20020559A2 (en) 2004-02-29
MA26862A1 (fr) 2004-12-20
ATE284380T1 (de) 2004-12-15
AU775918B2 (en) 2004-08-19
CA2395976A1 (fr) 2001-07-12
PL356056A1 (en) 2004-06-14
CN1414946A (zh) 2003-04-30
WO2001049650A1 (fr) 2001-07-12

Similar Documents

Publication Publication Date Title
BG106883A (en) Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
PL371414A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
ES2141688A1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
IL190905A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acids and processes for their prepatation
EP1466898A4 (fr) Inhibiteurs de la production/secretion de la proteine amyloide-beta
MY136269A (en) Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
BG106939A (en) Method for the preparation of citalopram
ATE251124T1 (de) Flammwidrige cyanatester
MXPA05013012A (es) Formulaciones blanqueadoras fluorescentes estables al almacenamiento.
BG105766A (en) New process for preparing pesticidal intermediates
IL153830A0 (en) A PROCESS FOR THE PREPARATION OF alpha' CHLOROKETONES
EP1390343A4 (fr) Nouveaux derives de retinoide, procedes de preparation de ces composes et composition pharmaceutique anti-cancer renfermant lesdits composes
MXPA01011104A (es) Procedimiento de sintesis de derivados n-(mercaptoail)-aminoacidos a partir de acidos acrilicos alfa substituidos.
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
AU3590801A (en) One-pot synthesis of alkyl 3-cyclopropylamino-2-(2,4-dibromo-3-(difluoromethoxy)benzoyl -2-propenoate as a useful intermediate for antibacterial quinolone medicaments
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
WO2005054175A3 (fr) Nouveau procede pour la preparation de derives nitro-oxy de paracetamol
IL158926A0 (en) Method for the production of biperidin
WO2005080329A3 (fr) Procede de preparation de carvedilol racemique
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA02012052A (es) Procedimiento para la obtencion de ciclohexiloxiacetatos de alquilo.
ZA200204594B (en) Vitamin D precursors, method and intermediates.
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
MXPA04001951A (es) Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos.